Complete Guide to Digoxin TDM Pharmacokinetics
Overview
Digoxin TDM is a Cardiac glycoside used in the Cardiovascular therapeutic area. It is indicated for Heart failure/AF. Therapeutic drug monitoring simulator for digoxin. Narrow TI, trough 0.8-2.0 ng/mL, CrCL-based clearance.
Key Pharmacokinetic Parameters
This popPK model for Digoxin TDM characterizes the time-course of drug concentrations following Oral administration. Key parameters such as clearance (CL), volume of distribution (Vd), and absorption rate constant (Ka) define the drug's disposition. Use the interactive simulator below to explore these parameters in detail.
Dosing & Administration
Digoxin TDM is administered via the Oral route. Oral administration involves absorption from the gastrointestinal tract, and bioavailability may be affected by food intake, formulation, and first-pass metabolism.
Dosing recommendations should always follow approved prescribing information. The interactive simulator allows you to explore different dosing scenarios and their impact on drug exposure metrics such as AUC, Cmax, and Ctrough.
Clinical Considerations
In the Cardiovascular therapeutic area, for the treatment of Heart failure/AF, understanding the pharmacokinetics of Digoxin TDM is essential for dose optimization and therapeutic drug monitoring. Key clinical factors that may affect Digoxin TDM pharmacokinetics include:
- •Body weight and body composition
- •Renal and hepatic function
- •Drug-drug interactions and concomitant medications
- •Age, sex, and genetic polymorphisms
Interactive Digoxin TDM PK Simulator
Explore Digoxin TDM pharmacokinetics interactively. Adjust doses, dosing intervals, and patient covariates to visualize concentration-time profiles in real time.
Frequently Asked Questions
What is the half-life of Digoxin TDM?
The elimination half-life of Digoxin TDM depends on patient-specific factors. Use our interactive Digoxin TDM PK simulator to explore concentration-time profiles and estimate half-life under different dosing scenarios.
How is Digoxin TDM administered?
Digoxin TDM is administered via the Oral route. It is indicated for Heart failure/AF. As a Cardiac glycoside, dosing regimens should follow approved prescribing information and clinical guidelines.
What are the key PK parameters of Digoxin TDM?
Key pharmacokinetic parameters for Digoxin TDM include clearance (CL), volume of distribution (Vd), and elimination half-life. Our interactive simulator uses a popPK model to characterize the pharmacokinetics of Digoxin TDM.
Can I simulate Digoxin TDM dosing scenarios for free?
Yes! PKPDBuilder offers a completely free, interactive Digoxin TDM PK simulator based on published pharmacometric models. No login required. Use it to explore different doses, dosing intervals, and patient covariates.
⚠️ Disclaimer
This guide is for research and educational purposes only. It is not intended for clinical decision-making or patient dosing. Parameters are derived from published literature and represent population estimates. Always consult approved prescribing information for clinical use.